Putting some extra pep in your step may prolong your life, according to a study published June 1 in the British Journal of Sports Medicine.

Virtual primary care visits for hypertension follow-ups are just as effective as in-person visits to maintain blood pressure control, according to a new study published on May 23 in the Journal of General Internal Medicine.

The electrical connection between the ventricular assist device (VAD)'s power source and its controller may be interrupted due to oxidation on the connecting surfaces, according to the agency’s recall notice.

Baylor St. Luke’s Medical Center in Houston has temporarily suspended its heart transplant program, two weeks after a joint investigation by the Houston Chronicle and ProPublica detailed its poor performance.

Type 2 diabetics who take sodium-glucose co-transporter-2 (SGLT-2) inhibitors experience similar relative reductions in heart failure and mortality regardless of whether they have cardiovascular disease (CVD), according to a subanalysis of the CVD-REAL study published in the Journal of the American College of Cardiology.

Avinger announced last week the FDA has approved its next-generation Pantheris Lumivascular atherectomy device, which is used to remove plaque from a blood vessel in those with peripheral artery disease (PAD).

ALISO VIEJO, Calif., May 31, 2018 — MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms.

Adding biomarkers to the validated Pooled Cohort Equation (PCE) can improve predictions of cardiovascular events including heart attack, stroke and heart failure among older patients, researchers reported in the Journal of the American College of Cardiology.